These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18765826)

  • 1. Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans.
    Huang RS; Duan S; Kistner EO; Hartford CM; Dolan ME
    Mol Cancer Ther; 2008 Sep; 7(9):3038-46. PubMed ID: 18765826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
    Huang RS; Duan S; Bleibel WK; Kistner EO; Zhang W; Clark TA; Chen TX; Schweitzer AC; Blume JE; Cox NJ; Dolan ME
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9758-63. PubMed ID: 17537913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.
    Huang RS; Duan S; Shukla SJ; Kistner EO; Clark TA; Chen TX; Schweitzer AC; Blume JE; Dolan ME
    Am J Hum Genet; 2007 Sep; 81(3):427-37. PubMed ID: 17701890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.
    O'Donnell PH; Gamazon E; Zhang W; Stark AL; Kistner-Griffin EO; Stephanie Huang R; Eileen Dolan M
    Pharmacogenet Genomics; 2010 May; 20(5):327-37. PubMed ID: 20393316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of genetic and functional genomics data to uncover chemotherapeutic induced cytotoxicity.
    Li R; Kim D; Wheeler HE; Dudek SM; Dolan ME; Ritchie MD
    Pharmacogenomics J; 2019 Apr; 19(2):178-190. PubMed ID: 29795408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic variants contributing to clofarabine cytotoxicity.
    Eadon MT; Wheeler HE; Stark AL; Zhang X; Moen EL; Delaney SM; Im HK; Cunningham PN; Zhang W; Dolan ME
    Hum Mol Genet; 2013 Oct; 22(19):4007-20. PubMed ID: 23720496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of genetic variants and gene expression relationships associated with pharmacogenes in humans.
    Huang RS; Duan S; Kistner EO; Zhang W; Bleibel WK; Cox NJ; Dolan ME
    Pharmacogenet Genomics; 2008 Jun; 18(6):545-9. PubMed ID: 18496134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.
    Wheeler HE; Gorsic LK; Welsh M; Stark AL; Gamazon ER; Cox NJ; Dolan ME
    PLoS One; 2011; 6(7):e21920. PubMed ID: 21755009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of the contribution of X chromosome genes to platinum sensitivity.
    Gamazon ER; Im HK; O'Donnell PH; Ziliak D; Stark AL; Cox NJ; Dolan ME; Huang RS
    Mol Cancer Ther; 2011 Mar; 10(3):472-80. PubMed ID: 21252287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.
    Hartford CM; Duan S; Delaney SM; Mi S; Kistner EO; Lamba JK; Huang RS; Dolan ME
    Blood; 2009 Mar; 113(10):2145-53. PubMed ID: 19109566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants contributing to daunorubicin-induced cytotoxicity.
    Huang RS; Duan S; Kistner EO; Bleibel WK; Delaney SM; Fackenthal DL; Das S; Dolan ME
    Cancer Res; 2008 May; 68(9):3161-8. PubMed ID: 18451141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of population and gender on chemotherapeutic agent-induced cytotoxicity.
    Huang RS; Kistner EO; Bleibel WK; Shukla SJ; Dolan ME
    Mol Cancer Ther; 2007 Jan; 6(1):31-6. PubMed ID: 17237264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility.
    Ziliak D; Gamazon ER; Lacroix B; Kyung Im H; Wen Y; Huang RS
    Mol Cancer Ther; 2012 Sep; 11(9):2054-61. PubMed ID: 22752226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
    Shukla SJ; Duan S; Wu X; Badner JA; Kasza K; Dolan ME
    Hum Genomics; 2009 Jan; 3(2):128-42. PubMed ID: 19164090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of common genetic variants that account for transcript isoform variation between human populations.
    Zhang W; Duan S; Bleibel WK; Wisel SA; Huang RS; Wu X; He L; Clark TA; Chen TX; Schweitzer AC; Blume JE; Dolan ME; Cox NJ
    Hum Genet; 2009 Feb; 125(1):81-93. PubMed ID: 19052777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide association study of serum uric acid in African Americans.
    Charles BA; Shriner D; Doumatey A; Chen G; Zhou J; Huang H; Herbert A; Gerry NP; Christman MF; Adeyemo A; Rotimi CN
    BMC Med Genomics; 2011 Feb; 4():17. PubMed ID: 21294900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies.
    Hao K; Chudin E; McElwee J; Schadt EE
    BMC Genet; 2009 Jun; 10():27. PubMed ID: 19531258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative "omic" analysis for tamoxifen sensitivity through cell based models.
    Weng L; Ziliak D; Lacroix B; Geeleher P; Huang RS
    PLoS One; 2014; 9(4):e93420. PubMed ID: 24699530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
    Shukla SJ; Duan S; Badner JA; Wu X; Dolan ME
    Pharmacogenet Genomics; 2008 Mar; 18(3):253-62. PubMed ID: 18300947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How well do HapMap SNPs capture the untyped SNPs?
    Tantoso E; Yang Y; Li KB
    BMC Genomics; 2006 Sep; 7():238. PubMed ID: 16982009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.